Skip to content
PubMed This is a summary of 95 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 95 referenced papers

Top Authors

Mrinal M. Gounder
Memorial Sloan Kettering Cancer Center
Bernd Kasper
Heidelberg University
Gary K. Schwartz
Case Comprehensive Cancer Center
Heidi L. Rehm
Broad Institute
Sue Richards
Oregon Health & Science University
Alessandro Gronchi
Fondazione IRCCS Istituto Nazionale dei Tumori
N. Jewel Samadder
Mayo Clinic in Florida
Nicolas Penel
Centre Oscar Lambret
Bente A. Talseth‐Palmer
New South Wales Department of Health
Jean‐Yves Blay
Centre Léon Bérard

Top Institutions

Ranked by publications Top 10 institutions
06

The University of Texas MD Anderson Cancer Center

Houston, United States

78 papers

References

References (95)
  1. 1

    Colorectal cancer: APC restores order.

    Seton-Rogers S

    Nature reviews. Cancer 2015; (15(8)):454 doi:10.1038/nrc3986.

    PMID: 26156639
  2. 2

    Desmoid tumors complicating Familial Adenomatous Polyposis: a meta-analysis mutation spectrum of affected individuals.

    Slowik V, Attard T, Dai H, et al.

    BMC gastroenterology 2015; (15()):84 doi:10.1186/s12876-015-0306-2.

    PMID: 26179480
  3. 3

    Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.

    Quast DR, Schneider R, Burdzik E, et al.

    Familial cancer 2016; (15(1)):31-40 doi:10.1007/s10689-015-9830-z.

    PMID: 26275868
  4. 4

    Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.

    Koskenvuo L, Peltomäki P, Renkonen-Sinisalo L, et al.

    Journal of surgical oncology 2016; (113(2)):209-12 doi:10.1002/jso.24117.

    PMID: 26663236
  5. 5

    Frequency and Features of Duodenal Adenomas in Patients With MUTYH-Associated Polyposis.

    Walton SJ, Kallenberg FG, Clark SK, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(7)):986-92.

    PMID: 26905905
  6. 6

    Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis.

    Quinn KP, Lightner AL, Pendegraft RS, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(9)):1296-301.

    PMID: 27085760
  7. 7

    Familial Adenomatous Polyposis.

    Waller A, Findeis S, Lee MJ

    Journal of pediatric genetics 2016; (5(2)):78-83 doi:10.1055/s-0036-1579760.

    PMID: 27617147
  8. 8

    Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis.

    Uchino S, Ishikawa H, Miyauchi A, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(12)):4611-4617 doi:10.1210/jc.2016-2043.

    PMID: 27623068
  9. 9

    Type and frequency of MUTYH variants in Italian patients with suspected MAP: a retrospective multicenter study.

    Ricci MT, Miccoli S, Turchetti D, et al.

    Journal of human genetics 2017; (62(2)):309-315 doi:10.1038/jhg.2016.132.

    PMID: 27829682
  10. 10

    The genetic basis of colonic adenomatous polyposis syndromes.

    Talseth-Palmer BA

    Hereditary cancer in clinical practice 2017; (15()):5 doi:10.1186/s13053-017-0065-x.

    PMID: 28331556
  11. 11

    Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

    Uzzan M, Kirchgesner J, Oubaya N, et al.

    Journal of Crohn's & colitis 2017; (11(8)):930-935 doi:10.1093/ecco-jcc/jjx027.

    PMID: 28333202
  12. 12

    Attenuated adenomatous polyposis of the large bowel: Present and future.

    Roncucci L, Pedroni M, Mariani F

    World journal of gastroenterology 2017; (23(23)):4135-4139 doi:10.3748/wjg.v23.i23.4135.

    PMID: 28694653
  13. 13

    NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?

    Weren RD, Ligtenberg MJ, Geurts van Kessel A, et al.

    The Journal of pathology 2018; (244(2)):135-142 doi:10.1002/path.5002.

    PMID: 29105096
  14. 14

    Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran

    Mirinezhad SK, Mousavi F, Baghri M, et al.

    Asian Pacific journal of cancer prevention : APJCP 2018; (19(1)):167-169 doi:10.22034/APJCP.2018.19.1.167.

    PMID: 29373909
  15. 15

    Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases.

    Akaishi J, Kondo T, Sugino K, et al.

    World journal of surgery 2018; (42(11)):3616-3623 doi:10.1007/s00268-018-4644-4.

    PMID: 29696324
  16. 16

    The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.

    Hurley JJ, Thomas LE, Walton SJ, et al.

    Gastrointestinal endoscopy 2018; (88(4)):665-673 doi:10.1016/j.gie.2018.04.2347.

    PMID: 29702101
  17. 17

    Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening.

    Trobaugh-Lotrario AD, López-Terrada D, Li P, Feusner JH

    Pediatric blood & cancer 2018; (65(8)):e27103 doi:10.1002/pbc.27103.

    PMID: 29719120
  18. 18

    Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?

    Morales A, Hershberger RE

    Circulation. Genomic and precision medicine 2018; (11(6)):e002169 doi:10.1161/CIRCGEN.118.002169.

    PMID: 29848615
  19. 19

    Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance.

    Neffa F, Garcia L, Della Valle A, et al.

    Journal of gastrointestinal oncology 2018; (9(3)):553-559 doi:10.21037/jgo.2017.10.06.

    PMID: 29998021
  20. 20

    Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review.

    Sada H, Hinoi T, Ueno H, et al.

    Surgery today 2019; (49(1)):72-81 doi:10.1007/s00595-018-1710-3.

    PMID: 30182306
  21. 21

    Life After Surgery: Surgeon Assessments of Quality of Life Among Patients With Familial Adenomatous Polyposis.

    Dossa F, Morris AM, Wilson AR, Baxter NN

    Diseases of the colon and rectum 2018; (61(10)):1217-1222 doi:10.1097/DCR.0000000000001146.

    PMID: 30192330
  22. 22

    A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.

    Majumder S, Shah R, Elias J, et al.

    PloS one 2018; (13(9)):e0203845 doi:10.1371/journal.pone.0203845.

    PMID: 30256815
  23. 23

    A novel large germ line deletion in adenomatous polyposis coli (APC) gene associated with familial adenomatous polyposis.

    Pouya F, Mojtabanezhad Shariatpanahi A, Ghaffarzadegan K, et al.

    Molecular genetics & genomic medicine 2018; (6(6)):1031-1040 doi:10.1002/mgg3.479.

    PMID: 30259713
  24. 24

    A Decision Analysis for Rectal-Sparing Familial Adenomatous Polyposis: Total Colectomy With Ileorectal Anastomosis Versus Proctocolectomy With IPAA.

    Melnitchouk N, Saadat LV, Bleday R, Goldberg JE

    Diseases of the colon and rectum 2019; (62(1)):27-32 doi:10.1097/DCR.0000000000001186.

    PMID: 30394986
  25. 25

    Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.

    Wang D, Liang S, Zhang X, et al.

    Molecular genetics & genomic medicine 2019; (7(1)):e00505 doi:10.1002/mgg3.505.

    PMID: 30523670
  26. 26

    Sorafenib for Advanced and Refractory Desmoid Tumors.

    Gounder MM, Mahoney MR, Van Tine BA, et al.

    The New England journal of medicine 2018; (379(25)):2417-2428 doi:10.1056/NEJMoa1805052.

    PMID: 30575484
  27. 27

    Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.

    Sutcliffe EG, Bartenbaker Thompson A, Stettner AR, et al.

    Familial cancer 2019; (18(2)):203-209 doi:10.1007/s10689-018-00116-2.

    PMID: 30604180
  28. 28

    Complications Related to J-Pouch Surgery.

    Freeha K, Bo S

    Gastroenterology & hepatology 2018; (14(10)):571-576.

    PMID: 30846911
  29. 29

    Balancing uncertainty with patient autonomy in precision medicine.

    Pollard S, Sun S, Regier DA

    Nature reviews. Genetics 2019; (20(5)):251-252 doi:10.1038/s41576-019-0111-9.

    PMID: 30872766
  30. 30

    Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis.

    Tajika M, Tanaka T, Ishihara M, et al.

    Endoscopy international open 2019; (7(5)):E691-E698 doi:10.1055/a-0849-9465.

    PMID: 31073536
  31. 31

    Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.

    Samadder NJ, Giridhar KV, Baffy N, et al.

    Mayo Clinic proceedings 2019; (94(6)):1084-1098 doi:10.1016/j.mayocp.2019.02.017.

    PMID: 31171119
  32. 32

    Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes.

    Samadder NJ, Baffy N, Giridhar KV, et al.

    Mayo Clinic proceedings 2019; (94(6)):1099-1116 doi:10.1016/j.mayocp.2019.01.042.

    PMID: 31171120
  33. 33

    Ileal-anal pouches: A review of its history, indications, and complications.

    Ng KS, Gonsalves SJ, Sagar PM

    World journal of gastroenterology 2019; (25(31)):4320-4342 doi:10.3748/wjg.v25.i31.4320.

    PMID: 31496616
  34. 34

    In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review.

    Rehan S, Aye K

    Clinical & experimental ophthalmology 2020; (48(1)):98-116 doi:10.1111/ceo.13643.

    PMID: 31525261
  35. 35

    Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy.

    Terlouw D, Suerink M, Singh SS, et al.

    European journal of human genetics : EJHG 2020; (28(2)):222-230 doi:10.1038/s41431-019-0509-z.

    PMID: 31527860
  36. 36

    Pathogenic APC Variants in Latvian Familial Adenomatous Polyposis Patients.

    Daneberga Z, Berzina D, Borosenko V, et al.

    Medicina (Kaunas, Lithuania) 2019; (55(10)) doi:10.3390/medicina55100612.

    PMID: 31547110
  37. 37

    [Meduloblastoma and recurrent meningioma in association with colonic polyposis: an unusual presentation of Turcot syndrome].

    Barreda Costa C, Chu Revollar L, Herrera Alzamora A

    Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 2019; (39(3)):280-283.

    PMID: 31688854
  38. 38

    c.1227_1228dupGG (p.Glu410Glyfs), a frequent variant in Tunisian patients with MUTYH associated polyposis.

    Kdissa A, Brusgaard K, Ksiaa M, et al.

    Cancer genetics 2020; (240()):45-53 doi:10.1016/j.cancergen.2019.10.007.

    PMID: 31739127
  39. 39

    Dento-osseous anomalies in patients with familial adenomatous polyposis: A follow-up study.

    Almeida FT, Leite AF, de Souza Figueiredo PT, et al.

    Clinical oral investigations 2020; (24(10)):3501-3511 doi:10.1007/s00784-020-03220-9.

    PMID: 32025882
  40. 40

    Does ileoanal pouch surgery increase the risk of desmoid in patients with familial adenomatous polyposis?

    Xie M, Chen Y, Wei W, et al.

    International journal of colorectal disease 2020; (35(8)):1599-1605 doi:10.1007/s00384-020-03578-y.

    PMID: 32435838
  41. 41

    Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.

    Takahashi T, Prensner JR, Robson CD, et al.

    Pediatric blood & cancer 2020; (67(10)):e28636 doi:10.1002/pbc.28636.

    PMID: 32762028
  42. 42

    Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response.

    Stefanski CD, Prosperi JR

    International journal of molecular sciences 2020; (21(21)) doi:10.3390/ijms21217844.

    PMID: 33105836
  43. 43

    Gardner syndrome with giant abdominal desmoid tumor during pregnancy: a case report.

    Jin L, Tan Y, Su Z, et al.

    BMC surgery 2020; (20(1)):282 doi:10.1186/s12893-020-00944-z.

    PMID: 33183289
  44. 44

    Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.

    Zhang Y, Liang B, Song X, et al.

    The American journal of pathology 2021; (191(5)):930-946 doi:10.1016/j.ajpath.2021.01.010.

    PMID: 33545120
  45. 45

    Next-Generation Sequencing for Non-Ampullary Duodenal Carcinoma Suggesting the Existence of an Adenoma-Carcinoma Sequence.

    Yoshida T, Kojima Y, Shimada R, et al.

    Case reports in gastroenterology 2021; (15(1)):62-69 doi:10.1159/000510919.

    PMID: 33613165
  46. 46

    Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).

    Ghadamyari F, Heidari MM, Zeinali S, et al.

    Journal of clinical laboratory analysis 2021; (35(5)):e23768 doi:10.1002/jcla.23768.

    PMID: 33769591
  47. 47

    Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.

    Ishikawa H, Mutoh M, Sato Y, et al.

    The lancet. Gastroenterology & hepatology 2021; (6(6)):474-481 doi:10.1016/S2468-1253(21)00018-2.

    PMID: 33812492
  48. 48

    Desmoid-type fibromatosis: toward a holistic management.

    Penel N, Kasper B, van Der Graaf WTA

    Current opinion in oncology 2021; (33(4)):309-314 doi:10.1097/CCO.0000000000000743.

    PMID: 33973549
  49. 49

    Early Development of Colonic Adenocarcinoma With Minimal Polyposis in a Young Child With Metastatic Hepatoblastoma and Germline APC Mutation.

    Liu APY, Chung PHY, Au Yeung RKH, et al.

    Journal of pediatric hematology/oncology 2021; (43(8)):e1191-e1193 doi:10.1097/MPH.0000000000002209.

    PMID: 34001798
  50. 50

    Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial.

    Balaguer F, Stoffel EM, Burke CA, et al.

    Diseases of the colon and rectum 2022; (65(4)):536-545 doi:10.1097/DCR.0000000000002095.

    PMID: 34261858
  51. 51

    Risk of extracolonic malignancies and metachronous rectal cancer after colectomy and ileorectal anastomosis in familial adenomatous polyposis.

    Sasaki K, Nozawa H, Kawai K, et al.

    Asian journal of surgery 2022; (45(1)):396-400 doi:10.1016/j.asjsur.2021.06.034.

    PMID: 34330586
  52. 52

    Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome.

    Mokhashi N, Cai LZ, Shields CL, et al.

    Current opinion in ophthalmology 2021; (32(6)):567-573 doi:10.1097/ICU.0000000000000798.

    PMID: 34456292
  53. 53

    Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.

    Soons E, Bisseling TM, van Kouwen MCA, et al.

    United European gastroenterology journal 2021; (9(4)):461-468 doi:10.1002/ueg2.12071.

    PMID: 34529357
  54. 54

    Attenuated Familial Adenomatous Polyposis: A Phenotypic Diagnosis but Obsolete Term?

    Anele CC, Martin I, McGinty Duggan PM, et al.

    Diseases of the colon and rectum 2022; (65(4)):529-535 doi:10.1097/DCR.0000000000002217.

    PMID: 34775416
  55. 55

    Validation of the Endoscopic Part of the Spigelman Classification for Evaluating Duodenal Adenomatosis in Familial Adenomatous Polyposis: A Prospective Study of Interrater and Intrarater Reliability.

    Karstensen JG, Bülow S, Burisch J, et al.

    The American journal of gastroenterology 2022; (117(2)):343-345 doi:10.14309/ajg.0000000000001582.

    PMID: 34913876
  56. 56

    Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care.

    Chiang J, Chia TH, Yuen J, et al.

    JCO precision oncology 2021; (5()):577-584 doi:10.1200/PO.20.00399.

    PMID: 34994607
  57. 57

    Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta-analysis.

    Aelvoet AS, Struik D, Bastiaansen BAJ, et al.

    Familial cancer 2022; (21(4)):429-439 doi:10.1007/s10689-022-00288-y.

    PMID: 35022961
  58. 58

    Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report.

    Khider F, Cherbal F, Boumehdi AL, et al.

    Molecular biology reports 2022; (49(5)):3823-3837 doi:10.1007/s11033-022-07228-0.

    PMID: 35142982
  59. 59

    Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

    Le Cosquer G, Buscail E, Gilletta C, et al.

    Cancers 2022; (14(3)) doi:10.3390/cancers14030530.

    PMID: 35158797
  60. 60

    Study of diagnostic value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.

    Cai S, Yu Y, Xie X, et al.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2022; (31(5)):422-429 doi:10.1097/CEJ.0000000000000725.

    PMID: 35191403
  61. 61

    Recent trends in the morbidity and mortality in patients with familial adenomatous polyposis: a retrospective single institutional study in Japan.

    Mori Y, Amano K, Chikatani K, et al.

    International journal of clinical oncology 2022; (27(6)):1034-1042 doi:10.1007/s10147-022-02146-4.

    PMID: 35274183
  62. 62

    Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

    Bonnet LA, Conway RM, Lim LA

    Clinical ophthalmology (Auckland, N.Z.) 2022; (16()):765-774 doi:10.2147/OPTH.S354761.

    PMID: 35321042
  63. 63

    Orbital osteomas associated with Gardner's syndrome: a case presentation and review of literature.

    Avila SA, Nguyen G, Wojno T, Kim HJ

    Orbit (Amsterdam, Netherlands) 2024; (43(1)):109-114 doi:10.1080/01676830.2022.2080231.

    PMID: 35652300
  64. 64

    Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights.

    Aelvoet AS, Buttitta F, Ricciardiello L, Dekker E

    Best practice & research. Clinical gastroenterology 2022; (58-59()):101793 doi:10.1016/j.bpg.2022.101793.

    PMID: 35988966
  65. 65

    Sexual Dysfunction in Female Patients with Inflammatory Bowel Disease: An Overview.

    Boyd T, de Silva PS, Friedman S

    Clinical and experimental gastroenterology 2022; (15()):213-224 doi:10.2147/CEG.S359367.

    PMID: 36540885
  66. 66

    Dysplasia at the Anal Transition Zone after IPAA.

    Church J

    Clinics in colon and rectal surgery 2022; (35(6)):495-498 doi:10.1055/s-0042-1758228.

    PMID: 36591401
  67. 67

    De novo familial adenomatous polyposis associated thyroid cancer with a c.2929delG frameshift deletion mutation in APC: a case report and literature review.

    Xu M, Zheng Y, Zuo Z, et al.

    World journal of surgical oncology 2023; (21(1)):73 doi:10.1186/s12957-023-02951-9.

    PMID: 36864485
  68. 68

    Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

    Gounder M, Ratan R, Alcindor T, et al.

    The New England journal of medicine 2023; (388(10)):898-912 doi:10.1056/NEJMoa2210140.

    PMID: 36884323
  69. 69

    A case of attenuated familial adenomatous polyposis in which genetic testing revealed that the children were asymptomatic gene carriers.

    Sonoda H, Yamada T, Yamaguchi T, et al.

    Japanese journal of clinical oncology 2023; (53(9)):866-869 doi:10.1093/jjco/hyad065.

    PMID: 37325944
  70. 70

    Predicting Duodenal Cancer Risk in Patients with Familial Adenomatous Polyposis Using Machine Learning Model.

    Akbulut S, Küçükakçalı Z, Çolak C

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2023; (34(10)):1025-1034 doi:10.5152/tjg.2023.22346.

    PMID: 37565794
  71. 71

    Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel.

    Spier I, Yin X, Richardson M, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(2)):100992 doi:10.1016/j.gim.2023.100992.

    PMID: 37800450
  72. 72

    Region-specific Wnt signaling responses promote gastric polyp formation in patients with familial adenomatous polyposis.

    McGowan KP, Delgado E, Keeley TM, et al.

    JCI insight 2023; (8(24)).

    PMID: 37943618
  73. 73

    A novel APC mutation associated with Gardner syndrome in a Chinese family.

    Zeng M, Yao X, Pan Y, et al.

    Gene 2024; (896()):148051 doi:10.1016/j.gene.2023.148051.

    PMID: 38043837
  74. 74

    Risk of Proctectomy After Ileorectal Anastomosis in Familial Adenomatous Polyposis in the Modern Era.

    Banerjee S, Burke CA, Sommovilla J, et al.

    Diseases of the colon and rectum 2024; (67(3)):427-434 doi:10.1097/DCR.0000000000003157.

    PMID: 38064246
  75. 75

    When Germline Genetic Testing Results Are Unclear: Highlighting Variants of Uncertain Significance.

    Kelly P, Mahon S, Friend P

    Journal of the advanced practitioner in oncology 2023; (14(7)):631-638 doi:10.6004/jadpro.2023.14.7.7.

    PMID: 38196669
  76. 76

    Histopathological Evaluation of Pouch Neoplasia in IBD and Familial Adenomatous Polyposis.

    Ko HM

    Diseases of the colon and rectum 2024; (67(S1)):S91-S98 doi:10.1097/DCR.0000000000003320.

    PMID: 38422398
  77. 77

    Adult pancreatoblastoma with atypical histological morphology combined with familial adenomatous polyposis: a rare case report.

    Wang YX, Fan SS, Peng XR, et al.

    Frontiers in oncology 2024; (14()):1346964 doi:10.3389/fonc.2024.1346964.

    PMID: 38482206
  78. 78

    Impact of Endoscopic Treatment in Severe Duodenal Polyposis: A National Study in Familial Adenomatous Polyposis Patients.

    Le Bras P, Cauchin E, De Lange G, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(9)):1839-1846.e1 doi:10.1016/j.cgh.2024.03.007.

    PMID: 38555039
  79. 79

    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.

    Zaffaroni G, Mannucci A, Koskenvuo L, et al.

    The British journal of surgery 2024; (111(5)) doi:10.1093/bjs/znae070.

    PMID: 38722804
  80. 80

    Active surveillance and emerging medical treatment options for desmoid: when and for whom?

    Bonvalot S, Miah A, Kasper B

    Current opinion in oncology 2024; (36(4)):263-268 doi:10.1097/CCO.0000000000001049.

    PMID: 38726846
  81. 81

    Current management of familial adenomatous polyposis.

    Lauricella S, Rausa E, Pellegrini I, et al.

    Expert review of anticancer therapy 2024; (24(6)):363-377 doi:10.1080/14737140.2024.2344649.

    PMID: 38785081
  82. 82

    Endoscopic management of patients with familial adenomatous polyposis after prophylactic colectomy or restorative proctocolectomy - systematic review of the literature.

    Gavric A, Sanchez LR, Brunori A, et al.

    Radiology and oncology 2024; (58(2)):153-169 doi:10.2478/raon-2024-0029.

    PMID: 38860690
  83. 83

    Development of Desmoid Tumors After Ileorectal Anastomosis Versus Ileal Pouch-Anal Anastomosis in Familial Adenomatous Polyposis.

    Aelvoet AS, Pellisé M, Miedema TN, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(11)):2319-2326 doi:10.1016/j.cgh.2024.06.018.

    PMID: 38969075
  84. 84

    Rare Germline Variants in the Adenomatous Polyposis Coli Gene Associated with Dental and Osseous Anomalies.

    Büki G, Antal G, Bene J

    International journal of molecular sciences 2024; (25(15)) doi:10.3390/ijms25158189.

    PMID: 39125758
  85. 85

    Familial adenomatous polyposis: a case report.

    Kindie EA, Beyera TD, Teferi ET, et al.

    Journal of medical case reports 2024; (18(1)):415 doi:10.1186/s13256-024-04724-8.

    PMID: 39244621
  86. 86

    Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.

    Fortuno C, Cops EJ, Davidson AL, et al.

    European journal of human genetics : EJHG 2024; (32(12)):1632-1639 doi:10.1038/s41431-024-01705-9.

    PMID: 39402389
  87. 87

    Use of congenital hypertrophy of the retinal pigment epithelium as a clinical sign of familial adenomatous polyposis.

    Carvalho AA, Crespo TS, Násser LS, et al.

    Arquivos brasileiros de oftalmologia 2024; (88(3)) doi:10.5935/0004-2749.2023-0115.

    PMID: 39607153
  88. 88

    Adenomatous Polyposis Coli Gene Mutations, Risk Factors, and Long-term Outcomes Associated With Desmoid Tumors in Patients With Familial Adenomatous Polyposis After Colectomy in Japan.

    Kojima T, Kurachi K, Iwaizumi M, et al.

    Journal of clinical gastroenterology 2025; (59(7)):583-591 doi:10.1097/MCG.0000000000002071.

    PMID: 39729982
  89. 89

    Late Diagnosis of Familial Adenomatous Polyposis After Acute Lower Gastrointestinal Bleeding: A Case Report.

    Logetto Caetité Gomes I, Silva Freire Junior R, Solidade Barreto L, et al.

    Cureus 2024; (16(12)):e76467 doi:10.7759/cureus.76467.

    PMID: 39867084
  90. 90

    Cancer Incidence and Mortality in Familial Adenomatous Polyposis Syndrome.

    Feldman D, Rodgers-Fouche LH, Ukaegbu C, et al.

    Diseases of the colon and rectum 2025; (68(5)):531-543 doi:10.1097/DCR.0000000000003645.

    PMID: 39932215
  91. 91

    [Proctocolectomy for familial adenomatous polyposis and other polyposis].

    Fernandez B, Buscail É

    Bulletin du cancer 2025; (112(3)):253-258 doi:10.1016/j.bulcan.2024.12.014.

    PMID: 39984364
  92. 92

    Germinal pathogenic CHEK2, novel APC and somatic JAK2V617F variants in a young patient with colorectal cancer, atypical leukemia, cerebral tumour and aggressive course.

    Rojas LXR, Rodriguez JAO, Navarrete SB, et al.

    Ecancermedicalscience 2025; (19()):1833 doi:10.3332/ecancer.2025.1833.

    PMID: 40177144
  93. 93

    Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies.

    Daca-Álvarez M, Latchford A, Pellisé M, Balaguer F

    Familial cancer 2025; (24(2)):53 doi:10.1007/s10689-025-00480-w.

    PMID: 40451978
  94. 94

    Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer.

    Tanakaya K, Yamaguchi T, Hirata K, et al.

    International journal of clinical oncology 2026; (31(1)):1-66 doi:10.1007/s10147-025-02892-1.

    PMID: 41214301
  95. 95

    Clinicopathological and molecular mechanisms of cribriform morular thyroid carcinoma: a case report and a literature review.

    Zhang X, Lv Y, Yan W, et al.

    Annals of medicine and surgery (2012) 2025; (87(12)):8944-8948 doi:10.1097/MS9.0000000000004082.

    PMID: 41377377